Menu Back to 7th-European-Forum-for-Qualified-Person-for-Pharmacovigilance-QPPV-17-18-April-2013-Pre-conference-Workshop-16-April-2013

Program Committee

  • Vicki  Edwards, RPh
    Vicki Edwards, RPh QPPV and Head of Affiliate Vigilance Excellence AbbVie Ltd., United Kingdom
  • Michael  Richardson, MD, FFPM
    Michael Richardson, MD, FFPM International Head GPV&E and EU QPPV Bristol-Myers Squibb, United Kingdom
  • Barbara  De Bernardi, MD
    Barbara De Bernardi, MD Deputy EU QPPV and European Safety Office Head Pfizer Italia S.r.l., Italy
  • Peter  De Veene, MD
    Peter De Veene, MD Executive Director, Clinical Safety and Pharmacovigilance Daiichi Sankyo Pharmaceuticals, United Kingdom
  • Margaret Anne Walters
    Margaret Anne Walters Director & Deputy EU Qualified Person for Pharmacovigilance Merck Sharp & Dohme Ltd., United Kingdom
  • Maarten  Lagendijk, MSc
    Maarten Lagendijk, MSc Pharmacovigilance Coordinator MEB, Netherlands
  • Brian David Edwards, MD, MRCP
    Brian David Edwards, MD, MRCP Vice President, ACRES; Principal Consultant, Pharmacovigilance and Drug Safety NDA Regulatory Science Ltd., United Kingdom
  • Elspeth  McIntosh
    Elspeth McIntosh Director Castle Pharmacovigilance Ltd, United Kingdom
Load More